Literature DB >> 889378

An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer.

R R Baker, E R Holmes, P O Alderson, N F Khouri, H N Wagner.   

Abstract

Preoperative bone scans were obtained in 104 patients with operable breast cancer. Areas of increased radioactivity detected by the bone scan were correlated with appropriate radiographs. One of 64 patients (1.5%) with clinical Stage I and Stage II breast cancer had a metastatic lesion detected by the preoperative bone scan. In contrast, 10 of 41 patients (24%) with Stage III breast cancer had occult metastatic lesions detected by the preoperative bone scan. The majority of patients with abnormal bone scans and no radiographic evidence of a benign lesion to explain the cause of the increased radioactivity proved to have metastatic breast cancer on follow-examination. Even though 20% of patients with operable breast cancer will eventually develop bone metastases, our results indicate that preoperative bone scans are not an effective means of predicting which patients with Stage I and Stage II disease will develop metastatic breast cancer. Because of the considerably increased frequency of detection of occult metastases in patients with Stage III breast cancer, bone scans should be obtained routinely in the preoperative assessment of these patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889378      PMCID: PMC1396331          DOI: 10.1097/00000658-197709000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Bone scintiscanning in the initial assessment of carcinoma of the breast.

Authors:  B C Lentle; P E Burns; H Dierich; F I Jackson
Journal:  Surg Gynecol Obstet       Date:  1975-07

2.  Radioisotopic detection of osseius metastases. Evaluation of 99mTc polyphosphate and 99mTc pyrophosphate.

Authors:  J W Fletcher; E Solaric-George; R E Henry; R M Donati
Journal:  Arch Intern Med       Date:  1975-04

3.  Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary cancer of the breast.

Authors:  D L Citrin; C M Furnival; R G Bessent; W R Greig; G Bell; L H Blumgart
Journal:  Surg Gynecol Obstet       Date:  1976-09

4.  Bone metastases from breast cancer at the time or radical mastectomy as detected by bone scan. Eight-year follow-up.

Authors:  R B Sklaroff; D M Sklaroff
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

5.  Metastatic bone disease developing in patients with potentially curable breast cancer.

Authors:  G F Robbins; W H Knapper; J Barrie; I Kripalani; J Lawrence
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

6.  Role of preoperative bone scan in carcinoma of the breast.

Authors:  A A El-Domeiri; S Shroff
Journal:  Surg Gynecol Obstet       Date:  1976-05

7.  Incidence and sites of bone lesions detected by 99mTc-polyphosphate scans in patients with tumors.

Authors:  R E Belliveau; R P Spencer
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

8.  Preoperative bone scans. Use in women with early breast cancer.

Authors:  N D Charkes; L S Malmud; T Caswell; L Goldman; J Hall; V Lauby; W Lightfoot; W Maier; G Rosemond
Journal:  JAMA       Date:  1975-08-11       Impact factor: 56.272

9.  The significance of occult skeletal metastases, detected by skeletal scintigraphy, in patients with otherwise apparently 'early' mammary carcinoma.

Authors:  C S Galasko
Journal:  Br J Surg       Date:  1975-09       Impact factor: 6.939

10.  Skeletal scintigraphy. The use of technetium 99M-labeled complexes in the detection of early osseous involvement by metastatic tumors.

Authors:  G B Hopkins; K A Kristensen; C G Campbell
Journal:  West J Med       Date:  1974-06
View more
  7 in total

1.  Clinical surveillance for early stage breast cancer: an analysis of claims data.

Authors:  M S Simon; M Stano; R K Severson; M S Hoff; D W Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  An analysis of the cost of clinical surveillance after primary therapy for women with early stage invasive breast cancer.

Authors:  M S Simon; M Stano; M Hussein; M Hoff; D Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Baseline staging tests in primary breast cancer: a practice guideline.

Authors:  R E Myers; M Johnston; K Pritchard; M Levine; T Oliver
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

4.  Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.

Authors:  K A Yeh; L Fortunato; J A Ridge; J P Hoffman; B L Eisenberg; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

5.  Breast cancer surveillance--a cost-effective strategy.

Authors:  D V Schapira
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology.

Authors:  M S Simon; M Hoff; M Hussein; S Martino; A Walt
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

7.  Intracranial meningioma, mimicking brain metastasis on 18F sodium fluoride bone scan in a case of carcinoma cervix.

Authors:  Rollapeta Ramya Priya; Ranadheer Gupta Manthri; Amancharla Yadagiri Lakshmi; Tekchand Kalawat
Journal:  Indian J Nucl Med       Date:  2016 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.